Note of concern: A Randomized Controlled Clinical Trial Investigating the Effect of
Synbiotic Administration on Markers of Insulin Metabolism and Lipid Profiles in
Overweight Type 2 Diabetic Patients with Coronary Heart Disease
M. Tajabadi-Ebrahimi
1
Faculty Member of Science Department, Science Faculty, Islamic Azad
University, Tehran Central branch, Tehran, Iran
,
N. Sharifi
2
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
A. Farrokhian
3
Department of Cardiology, School of Medicine, Kashan University of
Medical Sciences, Kashan, I.R. Iran
,
F. Raygan
3
Department of Cardiology, School of Medicine, Kashan University of
Medical Sciences, Kashan, I.R. Iran
,
F. Karamali
4
Rajaie Cardiovascular Medical and Research Center, Iran University of
Medical Sciences, Tehran, Iran
,
R. Razzaghi
5
Department of Infectious Disease, school of medicine, Kashan University
of Medical Sciences, Kashan, I.R. Iran
,
S. Taheri
2
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
,
Z. Asemi
2
Research Center for Biochemistry and Nutrition in Metabolic Diseases,
Kashan University of Medical Sciences, Kashan, I.R. Iran
A Randomized Controlled Clinical Trial Investigating the Effect of Synbiotic
Administration on Markers of Insulin Metabolism and Lipid Profiles in Overweight
Type 2 Diabetic Patients with Coronary Heart Disease
Tajabadi-Ebrahimi M et al. Exp Clin Endocrinol Diabetes 2017; 125 DOI
10.1055/s-0042-105441
Since publication of this article, serious concerns have been raised about the integrity of the reported
methods, results and analysis. Responses by the leading author and ethics committees
have been unsatisfactory and inconclusive; we advise readers to interpret the
information presented in the article with due caution.
